Tag Donat R. Spahn

Hematologic Risk Assessment

Hematologic risk assessment (HRA) involves evaluating and managing needs for red blood cell (RBC) transfusion as well as the integrity of a patient’s coagulation ability, including intrinsic bleeding disorders or coagulopathies and anticoagulant or antiplatelet medications. HRA is an essential…